Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.9313
Delayed Data
As of Dec 14
 -0.0187 / -1.97%
Today’s Change
0.72
Today|||52-Week Range
14.25
-78.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues3.1M3.5M3.9M4.2M
 
 
 
 
 
Cost of Goods Sold1.6M1.6M1.7M2.0M
 
 
 
 
 
Depreciation And Amortization993.0K972.0K965.0K876.0K
 
 
 
 
 
 
Operating ExpensesGross Income486.0K886.0K1.2M1.3M
 
 
 
 
 
General Expenses4.4M1.5M4.8M4.4M
 
 
 
 
 
Research And Development308.0K306.0K413.0K483.0K
 
 
 
 
 
Total Operating Expenses7.1M4.0M7.5M7.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-578.0K-3.6M-3.1M
 
 
 
 
 
Extraordinary Credit10.7M5.8M0.000.00
 
 
 
Extraordinary Charge0.00-3.0M-2.7M0.00
 
 
 
Interest Expense On Debt544.0K254.0K216.0K40.0K
 
 
 
 
 
Other Expenses0.00-36.0K-8.0K-294.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.2M1.9M-6.6M-3.4M
 
 
 
 
 
Income Taxes-108.0K-3.0K-301.0K-42.0K
 
 
 
 
 
Discontinued Operations-23.0K556.0K-54.0K71.0K
 
 
 
 
 
Net Income6.3M2.4M-6.3M-3.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.9M4.3M9.7M22.0M
 
 
 
 
 
Shares To Calculate EPS Diluted1.9M4.4M9.7M22.0M
 
 
 
 
 
 
Earnings Per ShareEPS$3.24$0.55-$0.65-$0.15
 
 
 
 
 
EPS Diluted$3.24$0.55-$0.65-$0.15